Quanterix (QTRX) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Quanterix Corporation  (NASDAQ: QTRX)
 

Quanterix Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Quanterix Corporation inventory turnover ratio, the Quanterix Corporation's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 1.73 in the third quarter 2026, yet the ratio remained below the average, as QTRX's market remain challenging.Average inventory processing period, for the Quanterix in Sep 30 2026 quarter, has decreased to 211 days, compare to 215 days, in the Jun 30 2026 quarter.

Within Healthcare sector 236 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1141 in the second quarter 2026, to 1648.

QTRX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Quanterix Corporation Market Share?

What is Inventory Turnover Ratio?




QTRX Inventory Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Inventory Growth -18.44 % 57.92 % 64.24 % 67.09 % 66.69 %
Y / Y Cost of Sales Growth -11.75 % 39.77 % 29.07 % 83.32 % 62.21 %
Inventory Turnover Ratio (TTM) 1.73 1.7 1.73 1.83 1.81
QTRX's Total Ranking # 1648 # 1141 # 1494 # 1041 #
Average inventory processing period 211 215 211 200 202
Seq. Inventory Growth -5.84 % -6.59 % -6.95 % -0.35 % 82.33 %
Seq. Cost of Sales Growth 6.14 % 1.16 % -16.03 % -2.12 % 68.1 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 14
Healthcare Sector # 237
Overall Market # 1648

Inventory Turnover Ratio Statistics
High Average Low
3.98 2.55 1.68
(Dec 31 2018)   (Jun 30 2026)




Financial Statements
Quanterix's Inventories $ 45 Millions Visit QTRX's Balance sheet
Quanterix's Cost of Revenues TTM $ 86 Millions Visit QTRX's Income Statement
What are QTRX's Sales? Visit QTRX's Sales by Segment

Other Inventory Turnover Ratios
Quanterix's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
QTRX's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for QTRX's Competitors
Inventory Turnover Ratio for QTRX's Suppliers
Inventory Turnover Ratio for QTRX's Customers

You may also want to know
QTRX's Sales Growth Rates QTRX's Pe Price to earnings ratio QTRX's Receivables Turnover Ratio QTRX's Stock Quote
QTRX's Net Income Growth Rates QTRX's Ps Price to Sales ratio QTRX's Sales per Employee QTRX's Asset Turnover Ratio
QTRX's Net Margin QTRX's Pb Price to Book ratio QTRX's Financial Strength Ratios QTRX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Abbott Laboratories  2.95 $ 20,765.000  Millions$ 7,032  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Zai Lab Limited  2.91 $ 200.083  Millions$ 69  Millions
Amneal Pharmaceuticals Inc   2.90 $ 1,910.255  Millions$ 658  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Ani Pharmaceuticals Inc  2.87 $ 405.540  Millions$ 142  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Dentsply Sirona Inc   2.65 $ 1,769.000  Millions$ 668  Millions
Avita Medical Inc   2.58 $ 14.936  Millions$ 6  Millions

Date modified: 2026-11-10T10:01:16+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.